Scientists Kill Brain Cancer with Quantum Therapy Spray. Researchers from the University of Nottingham have introduced an innovative spray treatment with the potential to combat glioblastoma, an extremely aggressive form of brain cancer responsible for over 10,000 annual deaths in the US.
This groundbreaking approach represents the first-ever quantum therapeutic method demonstrating the feasibility of cancer elimination through quantum signaling, specifically by inducing changes at the quantum level within cell biology.
Scientists Kill Brain Cancer with Quantum Therapy Spray:
The treatment revolves around the utilization of bio-nanoantennas, which are gold nanoparticles enveloped in redox-active molecules. The researchers propose to target glioblastoma cells by administering bio-nanoantennae via a spray to tumor sites and subsequently applying an electric field.
Frankie Rawson, one of the study’s authors and a research fellow at the University of Nottingham, described these remarkable particles as ‘bio-nanoantennae’ because they possess the ability to convert an electric field into a biological signaling event. This, in turn, regulates critical cell functions such as apoptosis, which is the process of programmed cell death.
In essence, this groundbreaking spray treatment could hold the key to a more effective and precise approach to tackling glioblastoma, offering hope to countless patients and their families.
Electrically Charged Bio-nanoantennae Kills Glioblastoma
According to the researchers, a grim reality confronts individuals diagnosed with glioblastoma: most do not survive beyond eight months post-diagnosis, and the five-year survival rate stands at a mere 6.8 percent.
The main culprit behind this dismal prognosis lies in the invasive nature of glioblastoma. These cancer cells infiltrate the adjacent brain tissue, rendering complete surgical removal nearly impossible. Even with the most aggressive treatment regimens, tumor recurrence remains inevitable.
In their study, the scientists propose a promising solution: by administering bio-nanoantennae via spray directly at the site of tumor surgical resection, these tiny structures are efficiently absorbed by the cancer cells.
Upon the application of an electric field, a fascinating process unfolds—a quantum electron transfer occurs at the surface of the bio-nanoantennae-bound protein known as cytochrome c. This novel approach opens up possibilities for more effective treatment strategies in the challenging battle against glioblastoma.
Read More: Pirola Covid Variant is Spreading Fast
The significance of this single electron transfer event cannot be overstated. It effectively changes the redox state of the protein, acting as a molecular signal to trigger programmed cell death within the cancer cells.
This intrinsic cellular response initiates a process where the cancer cells begin to self-destruct. This critical mechanism not only hinders tumor regrowth but also holds the potential to extend the lives of those battling glioblastoma.
What makes the bio-nanoantennae treatment truly captivating is its convergence of medical science and quantum bioelectronics. At its core, this method operates through a remarkable phenomenon known as quantum tunneling of electrons, scientifically termed Quantum Biological Electron Transfer (QBET).
Through QBET, the redox transformation of cytochrome C is activated, creating a vital signal that prompts cancer cells to initiate programmed cell death pathways through a one-electron transfer process within cytochrome C.
This extraordinary process not only showcases the potential of leveraging targeted electromagnetic fields but also underscores the ability of scientists to harness a quantum mechanical phenomenon within the realm of biology. It represents a pioneering fusion of quantum principles and medical science with the potential to revolutionize cancer treatment strategies.
For more information, please visit Munafa Marketing.